ARGEN-X
Live / Registered — Cancelled — Section 71 (as of 26 Feb 2021)
What this means for you
Registered since 25 May 2010. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79067634
- Registration number
- 3793242
- Mark type
- Word mark
- Filed
- 03 Apr 2009
- Published for opposition
- 09 Mar 2010
- Registered
- 25 May 2010
Goods and services
- Class 005 — Pharmaceuticals: Medicines, namely, antibodies for the treatment of infectious diseases and inflammation and for use in oncology [ ; medicines for the treatment of infectious diseases and inflammation and for use in oncology; medicines for autoimmune inflammatory disorders ]
- Class 042 — Scientific and technological services: Research and development in the field of biotechnology; research into new drugs and development of drugs; providing scientific and technical research services in the field of biotechnology and genetics; industrial analysis and research services in the field of biotechnology; laboratories, namely, medical laboratory services; providing information and advice in relation to the aforesaid services
Owner
Prosecution history
- 04 Jun 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 21 Jan 2022 — TOTAL INVALIDATION PROCESSED BY THE IB
- 23 Dec 2021 — GENERIC MADRID TRANSACTION SENT TO IB
- 22 Dec 2021 — GENERIC MADRID TRANSACTION CREATED
- 26 Oct 2021 — TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
- 26 Feb 2021 — CANCELLED SECTION 71
- 25 Jun 2020 — NEW REPRESENTATIVE AT IB RECEIVED
- 25 May 2019 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 18 Apr 2019 — INTERNATIONAL REGISTRATION RENEWED
- 04 Oct 2018 — NEW REPRESENTATIVE AT IB RECEIVED
- 24 May 2018 — CHANGE OF OWNER RECEIVED FROM IB
- 14 Dec 2017 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 01 Sept 2016 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 30 Jun 2016 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 30 Jun 2016 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.